Moderna Inc. (NASDAQ: MRNA) stock closed at 171.14 per share at the end of the most recent trading day (a -6.45% change compared to the prior day closing price) with a volume of 5.06M shares and market capitalization of 67.06B. Is a component of S&P 500, NASDAQ 100, Russell 1000 indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 1300 people. Moderna Inc. CEO is Stephane Bancel.

The one-year performance of Moderna Inc. stock is -62.53%, while year-to-date (YTD) performance is -32.62%. MRNA stock has a five-year performance of %. Its 52-week range is between 115.61 and 497.49, which gives MRNA stock a 52-week price range ratio of 14.62%

Moderna Inc. currently has a PE ratio of 4.90, a price-to-book (PB) ratio of 3.89, a price-to-sale (PS) ratio of 3.56, a price to cashflow ratio of 5.40, a PEG ratio of 2.32, a ROA of 73.94%, a ROC of 131.22% and a ROE of 141.44%. The company’s profit margin is 64.93%, its EBITDA margin is 73.30%, and its revenue ttm is $18.25 Billion , which makes it $45.87 revenue per share.

Of the last four earnings reports from Moderna Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $4.50 for the next earnings report. Moderna Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Moderna Inc. is Hold (2.67), with a target price of $229.42, which is +34.42% compared to the current price. The earnings rating for Moderna Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Moderna Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Moderna Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 20.66, ATR14 : 10.85, CCI20 : 41.49, Chaikin Money Flow : 0.06, MACD : 6.96, Money Flow Index : 43.13, ROC : 4.66, RSI : 44.74, STOCH (14,3) : 42.46, STOCH RSI : 0.41, UO : 53.38, Williams %R : -57.54), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Moderna Inc. in the last 12-months were: David W. Meline (Option Excercise at a value of $0), David W. Meline (Sold 619 shares of value $98 354 ), Elizabeth E. Tallett (Option Excercise at a value of $0), Elizabeth G. Nabel (Option Excercise at a value of $0), Juan Andres (Option Excercise at a value of $5 620 972), Juan Andres (Sold 440 309 shares of value $138 696 510 ), Noubar B. Afeyan (Option Excercise at a value of $0), Paul Sagan (Option Excercise at a value of $0), Paul Sagan (Sold 2 250 shares of value $708 525 ), Robert S. Langer (Option Excercise at a value of $0), Sandra J. Horning (Option Excercise at a value of $0), Shannon Thyme Klinger (Option Excercise at a value of $637 560), Shannon Thyme Klinger (Sold 1 265 shares of value $187 371 ), Stephane Bancel (Option Excercise at a value of $712 800), Stephane Bancel (Sold 1 553 500 shares of value $307 718 459 ), Stephen Berenson (Option Excercise at a value of $0), Stephen Hoge (Option Excercise at a value of $5 611 436), Stephen Hoge (Sold 593 305 shares of value $143 571 316 )